Geneva: Swiss pharmaceuticals giant Novartis is researching a vaccine for the H7N9 strain of bird flu, its chief executive said today, amid fears that the disease could mutate into a form that spreads among people.
Narendra Modi`s 17-point agenda for the nation
Power outage looms large as coal stocks dry
Bangalore rape case: NHRC slaps notice on govt
Don`t take us for granted, NCP warns Congress